Global radioligands trial phase 3 looks promising

[Maxone73]

using radioligands as first line in many different tumors seems to be effective

sunnybrook.ca/research/medi...

[GP24]

It works for neuroendocrine tumors only.

[TeleGuy in reply to GP24]

I think the thought was that earlier may be better for radioligand therapy though TA reported recently on some research that 177Lu-PSMA treatments are as effective before as after chemo. I have Lutathera on my radar screen given that I have neuroendocrine differentiation. and my biopsy samples stain positive for somatostatin, which the 177Lu-Dotatate (Lutathera) is attracted to.

[GP24 in reply to TeleGuy]

I wanted to point out that the article Maxone cited does not refer to "many different tumors" but reports treatment of neuroendocrine tumors only.

I had 177Lu-PSMA therapy while being hormone sensitive. Therefore I am for early radioligand therapy.

[TeleGuy in reply to GP24]

Me too, though early castrate resistant but before chemo.

[GP24 in reply to TeleGuy]

I think TA refered to this study: novartis.com/news/media-rel...

[DrawingSnowmen in reply to GP24]

“This trial is groundbreaking not only for patients with neuroendocrine cancers, but for all cancer patients as it has implications for the practice of cancer treatment broadly.”

[GP24 in reply to DrawingSnowmen]

The trial included patients with neuroendocrine tumors only. Therefore the results can only be applied to these tumors.

[j-o-h-n]

Remember, getting married also looked promising.

Good Luck, Good Health and Good Humor.

j-o-h-n

[Maxone73 in reply to j-o-h-n]

Damn right!